EUVIMEDObjevte EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Molecular nociceptive mechanisms in migraine: The migraine cascade

Song Guo iD, Sarah Louise Christensen, Mohammad Al-Mahdi Al-Karagholi, Jes Olesen iD

European Journal of Neurology · 2024-08 · 31 (8)

DOI: 10.1111/ene.16333 ↗

At a glance

Übersichtsarbeit in European Journal of Neurology, published online on 2024-06-18. Written by Song Guo and 3 co-authors. Institution: Danish Headache Center, Department of Neurology, Translational Research Center, Rigshospitalet-Glostrup, Faculty of Health and Medical Sciences, Univ…. Major MEDLINE topics: Migraine Disorders, Pituitary Adenylate Cyclase-Activating Polypeptide, Nociception. Cited 10 times so far (Crossref); 71 references. The full text is freely available (open access, CC BY 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Objective

This review will explore the categorization of migraine‐provoking molecules, their cellular actions, site of action and potential drug targets based on the migraine cascade model.

Methods

Personal experience and literature.

Results

Migraine impacts over 1 billion people worldwide but is underfunded in research. Recent progress, particularly through the human and animal provocation model, has deepened our understanding of its mechanisms. This model have identified endogenous neuropeptides such as calcitonin gene‐related peptide (CGRP) and pituitary adenylate cyclase‐activating peptide (PACAP) that induces controlled migraine‐like attacks leading to significant discoveries of their role in migraine. This knowledge led to the development of CGRP‐inhibiting drugs; a groundbreaking migraine treatment now accessible globally. Also a PACAP‐inhibiting drug was effective in a recent phase II trial. Notably, rodent studies have shed light on pain pathways and the mechanisms of various migraine‐inducing substances identifying novel drug targets. This is primarily done by using selective inhibitors that target specific signaling pathways of the known migraine triggers leading to the hypothesized cellular cascade model of migraine.

Conclusion

The model of migraine presents numerous opportunities for innovative drug development. The future of new migraine treatments is limited only by the investment from pharmaceutical companies.

Subjects

MeSH terms (MEDLINE)

Migraine DisordersPituitary Adenylate Cyclase-Activating PolypeptideNociceptionHumansAnimalsCalcitonin Gene-Related Peptide

Author keywords

CGRPPACAPanimal modelexperimental headachehuman provocation modelmigrainemigraine trigger

Substances

Pituitary Adenylate Cyclase-Activating PolypeptideCalcitonin Gene-Related Peptide

Authors and institutions

  • Danish Headache Center, Department of Neurology, Translational Research Center, Rigshospitalet-Glostrup, Faculty of Health and Medical Sciences, University of Copenhagen, Glostrup, Denmark.
  • Department of Neurology, Zealand University Hospital, Roskilde, Denmark.

ORCID profiles: Song Guo, Jes Olesen

Cite

APA

Guo, S., Christensen, S. L., Al-Karagholi, M. A., & Olesen, J. (2024). Molecular nociceptive mechanisms in migraine: The migraine cascade. European Journal of Neurology, 31(8). https://doi.org/10.1111/ene.16333

Vancouver

Guo S, Christensen SL, Al-Karagholi MA, Olesen J. Molecular nociceptive mechanisms in migraine: The migraine cascade. European Journal of Neurology. 2024;31(8). doi:10.1111/ene.16333

BibTeX
@article{Guo2024,
  author = {Guo, Song and Christensen, Sarah Louise and Al-Karagholi, Mohammad Al-Mahdi and Olesen, Jes},
  title = {Molecular nociceptive mechanisms in migraine: The migraine cascade},
  journal = {European Journal of Neurology},
  year = {2024},
  volume = {31},
  number = {8},
  doi = {10.1111/ene.16333}
}
Start for free →